Overview

Tanezumab In Osteoarthritis Of The Knee (2)

Status:
Completed

Trial end date:
2010-08-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Naproxen
Tanezumab